Contributing Factors to Diabetic Brain Injury and Cognitive Decline
Nirmal Verma (Verma N), Florin Despa (Despa F)
Diabetes Metab J. 2019;43(5):560-567.   Published online 2019 Oct 24     DOI: https://doi.org/10.4093/dmj.2019.0153
Citations to this article as recorded by Crossref logo
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
Geert Jan Biessels, Chloë Verhagen, Jolien Janssen, Esther van den Berg, Gudrun Wallenstein, Bernard Zinman, Mark A. Espeland, Odd Erik Johansen
Diabetologia.2021; 64(6): 1235.     CrossRef
The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol-Young Park
Journal of Alzheimer's Disease.2021; 81(3): 1263.     CrossRef
The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes
Jinni Meng, Yafei Zhu, Huixia Ma, Xiaobo Wang, Qipeng Zhao
Journal of Ethnopharmacology.2021; 280: 114464.     CrossRef
Letter: Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125–33)
Jin Hwa Kim
Diabetes & Metabolism Journal.2020; 44(2): 356.     CrossRef